Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

carmustine implant

(kar-MUS-teen IM-plant)
A drug used with surgery and radiation therapy to treat high-grade glioma that has not already been treated and with surgery to treat glioblastoma multiforme that has recurred (come back). Carmustine implant is a form of carmustine contained in a wafer. The wafer has a coating that dissolves slowly and releases carmustine directly into the area where the brain tumor was removed. This form may have fewer side effects and work better than other forms of carmustine. Carmustine implant is a type of alkylating agent and a type of nitrosourea. Also called Gliadel Wafer and polifeprosan 20 carmustine implant.
More Information
Search NCI's Dictionary of Cancer Terms